ATE516813T1 - Verfahren und verbindungen zur behandlung von diabetes - Google Patents

Verfahren und verbindungen zur behandlung von diabetes

Info

Publication number
ATE516813T1
ATE516813T1 AT05791454T AT05791454T ATE516813T1 AT E516813 T1 ATE516813 T1 AT E516813T1 AT 05791454 T AT05791454 T AT 05791454T AT 05791454 T AT05791454 T AT 05791454T AT E516813 T1 ATE516813 T1 AT E516813T1
Authority
AT
Austria
Prior art keywords
compounds
methods
treating diabetes
diabetes
treating
Prior art date
Application number
AT05791454T
Other languages
English (en)
Inventor
Per Berggren
Lisa-Juntti Berggren
Original Assignee
Biocrine Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocrine Ab filed Critical Biocrine Ab
Application granted granted Critical
Publication of ATE516813T1 publication Critical patent/ATE516813T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT05791454T 2004-08-26 2005-08-26 Verfahren und verbindungen zur behandlung von diabetes ATE516813T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60479204P 2004-08-26 2004-08-26
PCT/EP2005/009238 WO2006021451A2 (en) 2004-08-26 2005-08-26 Methods and compounds for treating diabetes

Publications (1)

Publication Number Publication Date
ATE516813T1 true ATE516813T1 (de) 2011-08-15

Family

ID=35694660

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05791454T ATE516813T1 (de) 2004-08-26 2005-08-26 Verfahren und verbindungen zur behandlung von diabetes

Country Status (6)

Country Link
EP (1) EP1819354B1 (de)
AT (1) ATE516813T1 (de)
DK (1) DK1819354T3 (de)
ES (1) ES2369919T3 (de)
PL (1) PL1819354T3 (de)
WO (1) WO2006021451A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ540597A (en) * 2005-06-08 2007-02-23 Neurotrophincell Pty Ltd A method for preventing the onset of type I diabetes comprising administering an implantable composition comprising living choroid plexus cells
WO2007111938A2 (en) 2006-03-23 2007-10-04 The General Hospital Corporation Inflammation-inhibitory serum factors and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE476188T1 (de) * 2002-05-14 2010-08-15 Nipro Corp Medikament zur prävention und behandlung von familiärer amyloid polyneuropathie
CA2800237C (en) * 2002-12-19 2016-05-17 The Scripps Research Institute Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding

Also Published As

Publication number Publication date
PL1819354T3 (pl) 2011-12-30
DK1819354T3 (da) 2011-09-12
ES2369919T3 (es) 2011-12-09
WO2006021451A3 (en) 2006-04-13
EP1819354A2 (de) 2007-08-22
EP1819354B1 (de) 2011-07-20
WO2006021451A2 (en) 2006-03-02

Similar Documents

Publication Publication Date Title
EA200900802A1 (ru) Способы и композиции для лечения амилоидных заболеваний
EA200600078A1 (ru) Способы и композиции для лечения амилоидных заболеваний
MX2009009738A (es) Tratamiento de degeneracion macular relacionada con la edad usando inhibidores de factor d de complemento.
EA200601555A1 (ru) Замещенные индазол-о-глюкозиды
ATE404574T1 (de) Verfahren zur inhibierung der proliferation von tumorzellen, bei dem platinkomplexe eingesetzt werden
BRPI0514017A (pt) indazóis úteis no tratamento de doenças cardiovasculares
EA200601554A1 (ru) Замещенные индол-о-глюкозиды
ATE429645T1 (de) Verwendung von eph-rezeptor-inhibitoren zur behandlung neurodegenerativer krankheiten
ATE448775T1 (de) Rifalazil zur behandlung von infektionen mit clostridium difficile
ATE428413T1 (de) Neue verwendung von peptidverbindungen zur behandlung ovn zentralen neuropathischen schmerzen
ATE504836T1 (de) Verfahren zur identifizierung von trpv2- modulatoren
DE602004021847D1 (de) Verfahren zur prävention und behandlung von diabetes mit neurturin
DE602005017373D1 (de) Verbindungen zur behandlung von schizophrenie und/oder glucoregulatorische auffälligkeiten
BRPI0417108A (pt) métodos de tratamento de rejeições de transplantes em pacientes
DE602007010459D1 (de) Verwendung von Verbindungen, die die EF-Tu-Nucleolin Wechselwirkung vehindern, zur Verhinderung oder Behandlung von Tularämie
EA200702212A1 (ru) Способ лечения или профилактики разрушения кости или остеопороза
NO20080037L (no) Kombinasjon av pyrimidylaminobenzamidforbindelser og imatinib for behandling eller forbyggelse av proliferative sykdommer
DE602004029061D1 (de) Zusammensetzungen, reagenzien, kits und verfahren für die diagnose und behandlung von fettleibigkeit und/oder diabetes
ATE549026T1 (de) Verwendung von pinitol zur behandlung von leberkrankheiten in säugetieren
TW200716132A (en) Novel chemical compounds
DE602005016141D1 (de) S-mirtazapin zur behandlung von hitzewallungen
ATE516813T1 (de) Verfahren und verbindungen zur behandlung von diabetes
DE60213365D1 (de) Verwendung von mglur5 antagonisten zur behandlung von pruritischen zuständen
ATE410235T1 (de) Behandlung von ballastwasser
DE602004022423D1 (de) Hemmung der s6-kinase-aktivität zur behandlung von insulinresistenz

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1819354

Country of ref document: EP